2026 Q1 Portfolio Activity
In 2026 Q1, Exome Asset Management LLC maintained a portfolio of 83 distinct positions. The most significant new addition was SPDR SERIES TRUST, now representing 3.96% of the total fund value. They heavily accumulated shares in CYTOKINETICS INC, increasing the position by 745.1%. Conversely, Exome Asset Management LLC completely exited their position in WAVE LIFE SCIENCES LTD.
Position History
hover any row below to update
Loading…
Total Positions
83
Quarter
2026 Q1
Top Holding
PRAX (7.6%)
Top 10 Concentration
42.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 83
Exome Asset Management LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 7.58% | 8.19% |
#1
Prev: #1
|
5.0 |
—
|
-12,653 | -21.8% |
P
S
|
45,469 | $14,649,657 |
$46.67
+636.2%
|
2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 5.54% | 5.19% |
#2
Prev: #2
|
4.2 |
—
|
-27,035 | -8.8% |
P
S
|
278,533 | $10,720,735 |
$5.99
+461.8%
|
2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 4.46% | 1.64% |
#3
18
Prev: #21
|
3.3 |
—
|
-2,217 | -1.0% |
P
S
|
220,091 | $8,627,567 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 4.27% | 4.41% |
#4
Prev: #4
|
2.7 |
—
|
-6,451 | -5.5% |
P
S
|
110,064 | $8,264,706 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 3.96% | — |
#5
Prev: #—
|
5.6 |
—
|
60,000 | — |
NEW
|
60,000 | $7,663,800 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GH
GUARDANT HEALTH...
|
Healthcare | 3.95% | 4.79% |
#6
3
Prev: #3
|
2.1 |
—
|
-15,446 | -15.7% |
P
S
|
82,736 | $7,642,324 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 3.54% | 3.79% |
#7
1
Prev: #6
|
1.9 |
—
|
-21,031 | -16.9% |
P
S
|
103,718 | $6,836,053 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 3.34% | 4.03% |
#8
3
Prev: #5
|
1.8 |
—
|
-840 | -10.7% |
P
S
|
7,012 | $6,449,427 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALMS
ALUMIS INC
|
Healthcare | 3.18% | 1.36% |
#9
22
Prev: #31
|
1.8 |
—
|
-13,074 | -4.5% |
P
S
|
279,176 | $6,150,247 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 2.59% | 2.95% |
#10
1
Prev: #9
|
1.5 |
—
|
-13,231 | -16.4% |
P
S
|
67,492 | $5,011,956 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 2.39% | 3.01% |
#11
3
Prev: #8
|
1.5 |
—
|
-9,400 | -7.6% |
P
S
|
114,991 | $4,626,088 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INSM
INSMED INC
|
Healthcare | 2.25% | — |
#12
Prev: #—
|
4.4 |
—
|
26,651 | — |
NEW
|
26,651 | $4,357,972 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ELV
ELEVANCE HEALTH...
|
Healthcare | 2.22% | 2.88% |
#13
3
Prev: #10
|
1.4 |
—
|
-2,514 | -14.6% |
P
S
|
14,677 | $4,296,692 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 2.19% | 1.78% |
#14
3
Prev: #17
|
1.4 |
—
|
-11,882 | -8.7% |
P
S
|
125,060 | $4,230,780 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 2.16% | 1.79% |
#15
1
Prev: #16
|
1.4 |
—
|
-632 | -8.2% |
P
S
|
7,053 | $4,182,288 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 2.08% | — |
#16
Prev: #—
|
4.3 |
—
|
215,376 | — |
NEW
|
215,376 | $4,014,609 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
PUT
CYTOKINETICS IN...
|
|
PUT Option | 2.05% | — |
#17
Prev: #—
|
4.3 |
—
|
60,000 | — |
NEW
|
60,000 | $3,954,600 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
NTRA
NATERA INC
|
Healthcare | 1.93% | 2.04% |
#18
5
Prev: #13
|
1.8 |
—
|
no change | no change |
P
S
|
18,650 | $3,729,814 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 1.83% | — |
#19
Prev: #—
|
4.2 |
—
|
40,581 | — |
NEW
|
40,581 | $3,529,330 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 1.80% | 0.92% |
#20
23
Prev: #43
|
3.7 |
—
|
7,027 | 120.4% |
P
S
|
12,862 | $3,480,329 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
APLS
APELLIS PHARMAC...
|
Healthcare | 1.78% | 1.63% |
#21
2
Prev: #23
|
0.7 |
—
|
-50,332 | -37.0% |
P
S
|
85,517 | $3,440,349 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VSTM
VERASTEM INC
|
Healthcare | 1.75% | 1.48% |
#22
7
Prev: #29
|
3.7 |
—
|
234,957 | 58.5% |
P
S
|
636,700 | $3,374,510 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TXG
10X GENOMICS IN...
|
Healthcare | 1.69% | 1.28% |
#23
10
Prev: #33
|
1.2 |
—
|
-9,464 | -5.8% |
P
S
|
154,194 | $3,273,539 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 1.57% | — |
#24
Prev: #—
|
4.1 |
—
|
48,347 | — |
NEW
|
48,347 | $3,033,774 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 1.54% | — |
#25
Prev: #—
|
4.1 |
—
|
84,103 | — |
NEW
|
84,103 | $2,973,882 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
CALL
BEONE MEDICINES...
|
|
CALL Option | 1.54% | — |
#26
Prev: #—
|
4.1 |
—
|
10,000 | — |
NEW
|
10,000 | $2,969,700 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 1.53% | — |
#27
Prev: #—
|
4.1 |
—
|
179,484 | — |
NEW
|
179,484 | $2,952,512 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 1.52% | 1.72% |
#28
9
Prev: #19
|
1.6 |
—
|
no change | no change |
P
S
|
6,358 | $2,930,974 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ADAG
ADAGENE INC
|
Healthcare | 1.49% | 0.96% |
#29
12
Prev: #41
|
0.6 |
—
|
-323,376 | -30.5% |
P
S
|
736,845 | $2,888,432 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 1.48% | 1.58% |
#30
4
Prev: #26
|
1.1 |
—
|
-4,037 | -8.1% |
P
S
|
45,721 | $2,866,707 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
CRESCENT BIOPHA...
|
|
Unknown | 1.46% | — |
#31
Prev: #—
|
4.1 |
—
|
153,191 | — |
NEW
|
153,191 | $2,814,119 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 1.43% | — |
#32
Prev: #—
|
4.1 |
—
|
278,302 | — |
NEW
|
278,302 | $2,769,105 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 1.37% | — |
#33
Prev: #—
|
4.0 |
—
|
88,510 | — |
NEW
|
88,510 | $2,642,024 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 1.27% | 1.52% |
#34
7
Prev: #27
|
0.5 |
—
|
-223,837 | -30.0% |
P
S
|
521,468 | $2,450,900 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 1.23% | — |
#35
Prev: #—
|
4.0 |
—
|
159,341 | — |
NEW
|
159,341 | $2,378,961 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
PUT
ALUMIS INC
|
|
PUT Option | 1.20% | 0.25% |
#36
19
Prev: #55
|
3.5 |
—
|
51,800 | 97.4% |
P
S
|
105,000 | $2,313,150 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
GKOS
GLAUKOS CORP
|
Healthcare | 1.16% | 1.70% |
#37
17
Prev: #20
|
0.5 |
—
|
-10,597 | -33.7% |
P
S
|
20,874 | $2,247,295 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CRBP
CORBUS PHARMACE...
|
Healthcare | 1.14% | 0.54% |
#38
13
Prev: #51
|
3.5 |
—
|
94,593 | 67.8% |
P
S
|
234,136 | $2,198,537 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PEN
PENUMBRA INC
|
Healthcare | 1.07% | 1.34% |
#39
7
Prev: #32
|
0.4 |
—
|
-2,700 | -30.0% |
P
S
|
6,300 | $2,068,731 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 1.07% | — |
#40
Prev: #—
|
3.9 |
—
|
61,673 | — |
NEW
|
61,673 | $2,064,812 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LQDA
LIQUIDIA CORPOR...
|
Healthcare | 0.89% | 1.50% |
#41
13
Prev: #28
|
0.4 |
—
|
-45,352 | -49.8% |
P
S
|
45,796 | $1,728,341 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZBIO
ZENAS BIOPHARMA...
|
Healthcare | 0.82% | — |
#42
Prev: #—
|
3.8 |
—
|
80,730 | — |
NEW
|
80,730 | $1,578,272 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
PUT
LIQUIDIA CORPOR...
|
|
PUT Option | 0.78% | — |
#43
Prev: #—
|
3.8 |
—
|
40,000 | — |
NEW
|
40,000 | $1,509,600 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
IMAB
NOVABRIDGE BIOS...
|
Unknown | 0.73% | 0.95% |
#44
2
Prev: #42
|
2.3 |
—
|
77,373 | 15.5% |
P
S
|
576,960 | $1,419,322 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
PUT
CENTESSA PHARMA...
|
|
PUT Option | 0.71% | — |
#45
Prev: #—
|
3.8 |
—
|
34,700 | — |
NEW
|
34,700 | $1,378,284 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
N/A
PUT
IDEAYA BIOSCIEN...
|
|
PUT Option | 0.69% | — |
#47
Prev: #—
|
3.8 |
—
|
40,000 | — |
NEW
|
40,000 | $1,332,800 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
N/A
CALL
IDEAYA BIOSCIEN...
|
|
CALL Option | 0.69% | — |
#46
Prev: #—
|
3.8 |
—
|
40,000 | — |
NEW
|
40,000 | $1,332,800 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
FDMT
4D MOLECULAR TH...
|
Healthcare | 0.63% | — |
#48
Prev: #—
|
3.8 |
—
|
130,564 | — |
NEW
|
130,564 | $1,215,551 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NXTC
NEXTCURE INC
|
Healthcare | 0.63% | 1.12% |
#49
13
Prev: #36
|
0.3 |
—
|
-49,500 | -30.0% |
P
S
|
115,500 | $1,215,060 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 0.54% | 0.85% |
#50
6
Prev: #44
|
0.2 |
—
|
-158,203 | -20.9% |
P
S
|
600,000 | $1,050,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 83 holdings